Study Summary
This trial will help determine whether a systematic geriatric assessment can improve the care of older myeloma patients by identifying and addressing problems that could impact their cancer outcomes.
- Multiple Myeloma
- Physical Disabilities
- Multiple Disabilities
Treatment Effectiveness
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 3 months from enrollment
Trial Safety
Trial Design
1 Treatment Group
Supportive Care
1 of 1
Experimental Treatment
40 Total Participants · 1 Treatment Group
Primary Treatment: Supportive care interventions · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 12 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the enrollment size of this clinical investigation?
"Affirmative. Data hosted on clinicaltrials.gov proves that the trial, which was originally posted on November 15th 2021 is actively enrolling patients. There are 40 positions available at a single medical facility." - Anonymous Online Contributor
Are there still opportunities available for individuals to join this trial?
"As per clinicaltrials.gov, this trial is actively looking for participants to join. It was initially posted on November 15th 2021 and the most recent update took place September 6th 2022." - Anonymous Online Contributor